Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Hao Wang, Sha Zhao, Xiaoshen Zhang, Keyi Jia, Juan Deng, Caicun Zhou & Yayi He. (2019) Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment. OncoTargets and Therapy 12, pages 7281-7288.
Read now
Read now
Marta Szajnik, Małgorzata Czystowska-Kuźmicz, Esther Elishaev & Theresa L. Whiteside. (2016) Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma. Expert Review of Molecular Diagnostics 16:8, pages 811-826.
Read now
Read now
Patrick J Stiff, Cheryl Czerlanis & Maureen L Drakes. (2013) Dendritic cell immunotherapy in ovarian cancer. Expert Review of Anticancer Therapy 13:1, pages 43-53.
Read now
Read now
Articles from other publishers (27)
Qin Zhao, Zifan Zhao, Jing Zhang, Yueqi Ni, Simin Ouyang, Haoning Qi, Yiqian Yu, Richard J. Miron, Hua Tang & Yufeng Zhang. (2023) Fn‐HMGB1 Adsorption Behavior Initiates Early Immune Recognition and Subsequent Osteoinduction of Biomaterials. Advanced Healthcare Materials.
Crossref
Crossref
Chenglin Li, Shuang Wang, Xiaoran Ma, Tiantian Wang, Ran Lu, Xihui Jia, Zhe Leng, Xiaowen Kong, Jinyu Zhang & Ling Li. (2023) Ranitidine as an adjuvant regulates macrophage polarization and activates CTLs through the PI3K-Akt2 signaling pathway. International Immunopharmacology 116, pages 109729.
Crossref
Crossref
Pierre V. Candelaria, Lai Sum Leoh, Manuel L. Penichet & Tracy R. Daniels-Wells. (2021) Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents. Frontiers in Immunology 12.
Crossref
Crossref
Qiu-Hui Zeng, Yuan Wei, Xiang-Ming Lao, Dong-Ping Chen, Chun-Xiang HuangQian-Yi LinMin HeYuan LiaoLimin ZhengBo LiGuang-Bo Zhang, Yun Chen & Dong-Ming Kuang. (2020) B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis. Science Advances 6:37.
Crossref
Crossref
Amber Gonda, Ron Moyron, Janviere Kabagwira, Paul A. Vallejos & Nathan R. Wall. 2020. Extracellular Vesicles and Their Importance in Human Health. Extracellular Vesicles and Their Importance in Human Health.
Song Liu, Junko Matsuzaki, Lei Wei, Takemasa Tsuji, Sebastiano Battaglia, Qiang Hu, Eduardo Cortes, Laiping Wong, Li Yan, Mark Long, Anthony Miliotto, Nicholas W. Bateman, Shashikant B. Lele, Thinle Chodon, Richard C. Koya, Song Yao, Qianqian Zhu, Thomas P. Conrads, Jianmin Wang, George L. Maxwell, Amit A. Lugade & Kunle Odunsi. (2019) Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Maria Muccioli, Harika Nandigam, Tiffany Loftus, Manindra Singh, Amritha Venkatesh, Julia Wright, Michelle Pate, Kelly McCall & Fabian Benencia. (2018) Modulation of double-stranded RNA pattern recognition receptor signaling in ovarian cancer cells promotes inflammatory queues. Oncotarget 9:94.
Crossref
Crossref
Grégory Noël, Mireille Langouo Fontsa & Karen Willard-Gallo. (2018) The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer. Seminars in Cancer Biology 52, pages 66-74.
Crossref
Crossref
Bernice Nounamo, Jason Liem, Martin Cannon & Jia Liu. (2017) Myxoma virus optimizes cisplatin for the treatment of ovarian cancer in vitro and in a syngeneic murine dissemination model. Molecular Therapy - Oncolytics.
Crossref
Crossref
M. Nayama, P. Collinet, M. Salzet & D. Vinatier. (2016) Aspects immunologiques du cancer de l’ovaire : perspectives thérapeutiques. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 45:9, pages 1020-1036.
Crossref
Crossref
Yu-Zhen Wang & Sheng-Chun Qiu. (2016) Prediction of key genes in ovarian cancer treated with decitabine based on network strategy. Oncology Reports.
Crossref
Crossref
Martin Cannon, Debopam Ghosh & Swetha Gujja. (2015) Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages. Vaccines 3:2, pages 448-466.
Crossref
Crossref
LIHONG CHEN, DU MENG, LEI ZHAO, RUI LIU, PEISONG BAI, LE WANG & JUXIANG XIAO. (2015) Selective colorectal cancer cell lysates enhance the immune function of mature dendritic cells in vitro. Molecular Medicine Reports 11:3, pages 1877-1884.
Crossref
Crossref
H. M. Rostam, S. Singh, N. E. Vrana, M. R. Alexander & A. M. Ghaemmaghami. (2015) Impact of surface chemistry and topography on the function of antigen presenting cells. Biomaterials Science 3:3, pages 424-441.
Crossref
Crossref
Rong-Hang Hu, Sheng-Bin Shi, Jie-Lin Qi, Jing Tian, Xiao-Yong Tang, Guo-Fang Liu & Chun-Xiao Chang. (2014) Pemetrexed plus dendritic cells as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer who had treatment with TKI. Medical Oncology 31:8.
Crossref
Crossref
Junko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, Lloyd J. Old, Protul Shrikant, Sacha Gnjatic & Kunle Odunsi. (2014) Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells. Cancer Immunology Research 2:4, pages 341-350.
Crossref
Crossref
Vincent Lavoué, Aurélie Thédrez, Jean Levêque, Fabrice Foucher, Sébastien Henno, Vincent Jauffret, Marc-Antoine Belaud-Rotureau, Veronique Catros & Florian Cabillic. (2013) Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer. Journal of Translational Medicine 11:1.
Crossref
Crossref
Jaikumar Duraiswamy, Gordon J. Freeman & George Coukos. (2013) Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer. Cancer Research 73:23, pages 6900-6912.
Crossref
Crossref
Zhenqun Xu, Lan Zhao, Ling-Yan Zhu, Min He, Limin Zheng & Yan Wu. (2013) MicroRNA-17, 20a Regulates the Proangiogenic Function of Tumor-Associated Macrophages via Targeting Hypoxia-Inducible Factor 2α. PLoS ONE 8:10, pages e77890.
Crossref
Crossref
Michael J. Bradaric, Krishna Penumatsa, Animesh Barua, Seby L. Edassery, Yi Yu, Jacques S. Abramowicz, Janice M. Bahr & Judith L. Luborsky. (2013) Immune Cells in the Normal Ovary and Spontaneous Ovarian Tumors in the Laying Hen (Gallus domesticus) Model of Human Ovarian Cancer. PLoS ONE 8:9, pages e74147.
Crossref
Crossref
Cherifa Ayari, Hélène LaRue, Hélène Hovington, André Caron, Alain Bergeron, Bernard Têtu, Vincent Fradet & Yves Fradet. (2013) High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer. Human Pathology 44:8, pages 1630-1637.
Crossref
Crossref
Stefanie Trojandt, Diana Knies, Stefanie Pektor, Sandra Ritz, Volker Mailänder, Stephan Grabbe, Angelika B. Reske-Kunz & Matthias Bros. (2013) The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells. Cancer Immunology, Immunotherapy 62:8, pages 1315-1326.
Crossref
Crossref
S. Hanssen, P. Collinet, E. Leblanc, M. Salzet & D. Vinatier. (2013) Analogies immunologiques du cancer de l’ovaire et de la grossesse. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 42:3, pages 217-226.
Crossref
Crossref
Dmitriy W. Gutkin. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment
39
82
.
Yang Ma, Galina V. Shurin, Dmitriy W. Gutkin & Michael R. Shurin. (2012) Tumor associated regulatory dendritic cells. Seminars in Cancer Biology 22:4, pages 298-306.
Crossref
Crossref
Uciane K. Scarlett, Melanie R. Rutkowski, Adam M. Rauwerdink, Jennifer Fields, Ximena Escovar-Fadul, Jason Baird, Juan R. Cubillos-Ruiz, Ana C. Jacobs, Jorge L. Gonzalez, John Weaver, Steven Fiering & Jose R. Conejo-Garcia. (2012) Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. Journal of Experimental Medicine 209:3, pages 495-506.
Crossref
Crossref
Lin Xu, Chunhong Wang, Ya Zhou, Tao Ren & Zhenke Wen. (2012) CpG oligonucleotides induce the differentiation of CD4+Th17 cells by triggering plasmacytoid dendritic cells in adoptively cell transfer immunotherapy. Immunology Letters 142:1-2, pages 55-63.
Crossref
Crossref